GlassScriptPhysician profile
Bruce D Fischer
NPI 1881674349
$3,928.25
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $276 · 2021: $601 · 2022: $651 · 2023: $769 · 2024: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $695.27 | 2019-2024 | Puraply, Affinity, Nushield |
| Arthrosurface Incorporated | $600.00 | 2019 | |
| Smith+Nephew, INC. | $450.85 | 2019-2024 | Renasys Touch, Pico, Renasys Go V2 Home |
| Paratek Pharmaceuticals, INC. | $337.39 | 2021-2024 | Nuzyra |
| Misonix INC | $287.39 | 2019-2021 | |
| Bioventus LLC | $258.31 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $257.28 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo |
| Reddress USA, INC. | $207.23 | 2024 | |
| Amgen INC. | $140.00 | 2024 | Krystexxa |
| Lifenet Health | $83.80 | 2023 | |
| Treace Medical Concepts, INC. | $66.03 | 2022 | |
| Horizon Therapeutics Plc | $48.53 | 2019-2021 | |
| Reprise Biomedical, INC. | $47.45 | 2021-2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $42.53 | 2022-2024 | Topical Oxygen Chamber For Extremities |
| Musculoskeletal Transplant Foundation INC. | $40.62 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $38.75 | 2021-2022 | |
| Kerecis Limited | $36.59 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Djo, LLC | $36.20 | 2019 | |
| Averitas Pharma INC. | $34.72 | 2023 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $33.63 | 2023 | Seglentis |
| Grt US Holding, INC. | $23.65 | 2022 | |
| Solventum Corporation | $22.40 | 2024 | Activ.A.C., Promogran Prisma |
| Bsn Medical INC | $19.64 | 2020 | |
| Medtronic, INC. | $19.46 | 2021 | |
| Hydrofera LLC | $16.70 | 2022 | |
| Integra Lifesciences Corporation | $16.51 | 2020 | |
| Mimedx Group, INC. | $14.70 | 2024 | |
| Melinta Therapeutics, LLC | $14.38 | 2019 | |
| Heron Therapeutics, INC. | $13.62 | 2022 | |
| Paragon 28, INC. | $12.47 | 2021 | |
| Merck Sharp & Dohme LLC | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.